# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001641172-25-015355
Filing Date
2025-06-17
Accepted
2025-06-17 10:32:42
Documents
23
Period of Report
2025-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8-k.htm iXBRL | 8-K | 43569
2 | EX-10.1 | ex10-1.htm | EX-10.1 | 9255
3 | EX-99.1 | ex99-1.htm | EX-99.1 | 16786
4 | GRAPHIC | ex10-1_001.jpg | GRAPHIC | 1125897
5 | GRAPHIC | ex10-1_002.jpg | GRAPHIC | 1070954
6 | GRAPHIC | ex10-1_003.jpg | GRAPHIC | 1034802
7 | GRAPHIC | ex10-1_004.jpg | GRAPHIC | 1079460
8 | GRAPHIC | ex10-1_005.jpg | GRAPHIC | 1121286
9 | GRAPHIC | ex10-1_006.jpg | GRAPHIC | 1145694
10 | GRAPHIC | ex10-1_007.jpg | GRAPHIC | 823803
11 | GRAPHIC | ex10-1_008.jpg | GRAPHIC | 348394
12 | GRAPHIC | ex10-1_009.jpg | GRAPHIC | 591396
| Complete submission text file | 0001641172-25-015355.txt |  | 11728015

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL SCHEMA FILE | pcsa-20250617.xsd | EX-101.SCH | 3059
14 | XBRL LABEL FILE | pcsa-20250617_lab.xml | EX-101.LAB | 34239
15 | XBRL PRESENTATION FILE | pcsa-20250617_pre.xml | EX-101.PRE | 22388
25 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3698

Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 251052224
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)